Hema.to ^Company

Hema.to is an organization that specializes in providing fully automated, AI-powered blood cancer detection suggestions based on flow cytometry data. Their main goal is to increase efficiency and quality for hemato-oncology labs by reducing the time to diagnosis and increasing throughput. Users have full control over the extent of decision support they employ, with the confidence of hema.to's diagnostic recommendation made transparent for each case. The organization also offers the ability to explain the clinical reasoning behind a diagnosis, allowing users to configure, adapt, and export medical reports in seconds. Hema.to is a CE-IVD product and is scientifically backed by peer-reviewed publications, ensuring that it meets the highest standards in medical software development.